Cytotoxic therapy in rheumatoid arthritis.
D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents / Q000627:therapeutic use* / Q000633:toxicity; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007109:Immunity / Q000187:drug effects; D008466:Mechlorethamine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use
D000970:Antineoplastic Agents; D008466:Mechlorethamine; D003520:Cyclophosphamide; D001379:Azathioprine; D008727:Methotrexate